Stryker Corporation

Stock Symbol: SYK

Stryker Corporation Description:
Stryker Corporation develops, manufactures and markets specialty surgical and medical products, including orthopaedic reconstructive, trauma, spinal and craniomaxillofacial implants, the bone growth factor osteogenic protein-1, powered surgical instruments, endoscopic systems, patient care and handling equipment for the global market, and provides outpatient physical therapy services in the United States.

Stryker Corporation Financial Summary:
For the nine months ended 30 September 2005, Stryker Corporation's sales increased 16% to $3.59B. Net income for the period increased 62% to $489.5M. Revenues reflect strong shipments of Orthopaedic Implants and MedSurg Equipment. Higher net income reflects the absence of a $120.8M charge to writeoff purchased in-process research and development associated with the acquisition of SpineCore, Inc.

Stryker Corporation Business Summary:
Stryker Corporation (Stryker) manufactures and markets medical devices primarily to the orthopedic market. The Company segregates its operations into two reportable business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, spine and micro implant systems, bone cement and the bone growth factor OP-1. The MedSurg Equipment segment sells powered surgical instruments, surgical navigation systems, endoscopic products, medical video imaging equipment, and hospital beds and stretchers. The Other category includes Physical Therapy Services and corporate administration, interest expense and interest income. In the year ended December 31, 2004, the Company completed its acquisition, by merger, of SpineCore, Inc. (SpineCore), a developer of artificial lumbar and cervical discs.